ORI Healthcare Fund L.P., a venture capital firm founded by the formerly head of China Healthcare at Goldman Sachs, has led a US$100 million series C round in U.K. biopharmaceutical company Kymab Group Ltd. Wellcome Trust, Bill & Melinda Gates Foundation, Shenzhen Hepalink Pharmaceutical Co., Ltd, Malin Corporation PLC; CF Woodford Equity Income Fund and […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.